Enhanced tight junction function in human breast cancer cells by antioxidant, selenium and polyunsaturated lipid

Journal of Cellular Biochemistry

Volumn 101, Issue 1, 2007, Pages 155-166

  Martin, Tracey A ^a   Das, Tapas ^b   Mansel, Robert E ^a   Jiang, Wen G ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b ABBOTT LABORATORIES   (United States)

Author keywords

Breast cancer; GLA (gamma linolenic acid); Invasion; Iodine; Selenium; Tight junctions

Indexed keywords

ESTRADIOL; GAMMA LINOLENIC ACID; IODINE; OCCLUDIN; PROTEIN ZO1; SELENIUM;

ARTICLE; BREAST CANCER; BREAST METASTASIS; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER INVASION; CELL ADHESION; CELL JUNCTION; CELL MEMBRANE PERMEABILITY; CELL MOTILITY; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG MIXTURE; ENDOTHELIUM CELL; EPITHELIUM CELL; ESTROGEN ACTIVITY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; PRIORITY JOURNAL; TIGHT JUNCTION;

ANTIOXIDANTS; BREAST NEOPLASMS; CELL CULTURE TECHNIQUES; CELL LINE; CELL LINE, TUMOR; CELL MEMBRANE PERMEABILITY; CELL MOVEMENT; ELECTRIC IMPEDANCE; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; EPITHELIAL CELLS; ESTRADIOL; FEMALE; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; FLUORESCENT DYES; GAMMA-LINOLENIC ACID; HUMANS; MEMBRANE PROTEINS; PHOSPHOPROTEINS; SELENIUM; TIGHT JUNCTIONS;

EID: 34247517828     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21162     Document Type: Article

References (44)

1. Breedlove HA, Smith AM, Burk RF, Hill KE, Shapiro CL. 2006. Serum selenium measurements in women with early-stage breast cancer with and without chemotherapy-induced ovarian failure. Breast Cancer Res Treat 97(3):225-230.
2. Cann SA, van Netten JP, van Netten C. 2000. Hypothesis: Iodine, selenium and the development of breast cancer. Cancer Causes Control 11:121-127.
3. Daro AF, Gollin HA, Samos FH. 1964. The effect of thyroid on cystic mastitis. J Int Coll Surg 41:58-59.
4. Demirel-Yilmaz E, Dincer D, Yilmaz G, Turan B. 1998. The effect of selenium and vitamin E on microvascular permeability of rat organs. Biol Trace Elem Res 64(1-3):161-168.
5. Eskin BA, Grotkowski CE, Connolly CP, Ghent WR. 1995. Different tissue responses for iodine and iodide in rat thyroid and mammary glands. Biol Trace Elem Res 49(1):9-19.
6. Estes NC. 1981. Mastodynia due to fibrocystic disease of the breast controlled with thyroid hormone. Am J Surg 142(6):764-766.
7. Fanning NF, Manning BJ, Buckley J, Redmond HP. 2002. Iodinated contrast media induce neutrophil apoptosis through a mitochondrial and caspase mediated pathway. Br J Radiol 75(899);861-873.
8. Furuse M, Fujita K, Hiiragi T, Fujimoto K, Tsukita S. 1998. Claudin-1 and -2: Novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J Cell Biol 141(7):1539-1550.
9. Ghent WR, Eskin BA, Low DA, Hill LP. 1993. Iodine replacement in fibrocystic disease of the breast. Can J Surg 36(5):453-460.
10. Glukhova M, Koteliansky V, Sastre X, Thiery JP. 1995. Adhesion systems in normal breast and in invasive breast carcinoma. Am J Pathol 146(3):706-716.
11. Gorodeski GI. 2000. Effects of menopause and 17beta-estradiol on cervical epithelial permeability. J Clin Endocrinol Metab 85(7):2584-2595.
12. Gupta S, Narang R, Krishnaswami K, Yadav S. 1994. Plasma selenium level in cancer patients. Indian J Cancer 31(3):192-197.
13. Hoevel T, Macek R, Mundigl O, Swisshelm K, Kubbies M. 2002. Expression and targeting of the tight junction protein CLDN1 in CLDN1-negative human breast tumor cells. J Cell Physiol 191(1):60-68.
14. Hoover KB, Liao SY, Bryant PJ. 1998. Loss of the tight junction MAGUK ZO-1 in breast cancer: Relationship to glandular differentiation and loss of heterozygosity. Am J Pathol 153(6):1767-1773.
15. Ip C, Ganther HE. 1991. Combination of blocking agents and suppressing agents in cancer prevention. Carcinogenesis 12(2):365-367.
16. Itoh M, Bissell MJ. 2003. The organization of tight junctions in epithelia: Implications for mammary gland biology and breast tumorigenesis. J Mammary Gland Biol Neoplasia 8(4):449-462.
17. Jahnova E, Horvathova M, Gazdik F, Weissova S. 2002. Effects of selenium supplementation on expression of adhesion molecules in corticoid-dependent asthmatics. Bratisl Lek Listy 103(1):12-16.
18. Jiang WG, Hiscox S, Hallett MB, Horrobin DF, Mansel RE, Puntis MC. 1995. Regulation of the expression of E-cadherin on human cancer cells by gamma-linolenic acid (GLA). Cancer Res 55(21):5043-5048.
19. Jiang WG, Bryce RP, Horrobin DF, Mansel RE. 1998. Regulation of tight junction permeability and occludin expression by polyunsaturated fatty acids. Biochem Biophys Res Commun 244(2):414-420.
20. Jiang C, Jiang W, Ip C, Ganther H, Lu J. 1999. Selenium-induced inhibition of angiogenesis in mammary cancer at chemopreventive levels of intake. Mol Carcinog 26(4):213-225.
21. Kominsky SL, Argani P, Korz D, Evron E, Raman V, Garrett E, Rein A, Sauter G, Kallioniemi OP, Sukumar S. 2003. Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Oncogene 22(13):2021-2033.
22. Kowaltowski AJ, Netto LE, Vercesi AE. 1998. The thiol-specific antioxidant enzyme prevents mitochondrial permeability transition. Evidence for the participation of reactive oxygen species in this mechanism. J Biol Chem 273(21):12766-12769.
23. Lee SO, Nadiminty N, Wu XX, Lou W, Dong Y, Ip C, Onate SA, Gao AC. 2005. Selenium disrupts estrogen signalling by altering estrogen receptor expression and ligand binding in human breast cancer cells. Cancer Res 65(8):3487-3492.
24. Lu J. 2001. Apoptosis and angiogenesis in cancer prevention by selenium. Adv Exp Med Biol 492:131-145.
25. Martin TA, Matsumoto K, Nakamura T, Mansel RE, Jiang WG. 2000. A combination of NK4, a HGF/SF variant and gamma linolenic acid (GLA) increases inhibition of HGF/ SF stimulated human vascular endothelial angiogenesis. Breast Cancer Res Treat 64(1):133.
26. Martin TA, Watkins G, Mansel RM, Jiang WG. 2004. Hepatocyte growth factor disrupts tight junctions in human breast cancer cells. Cell Biol Int 28(5):361-371.
27. Martin TA, Das T, Mansel RM, Jiang WG. 2006. Synergistic regulation of endothelial tight junctions by antioxidant (Se) and polyunsaturated lipid (GLA) via Claudin-5 modulation. J Cell Biochem 98(5):1308-1319. [Epub ahead of print] 10.1002/jcb.20860.
28. Martinez-Estrada OM, Culleres A, Soriano FX, Peinado H, Bolos V, Martinez FO, Reina M, Cano A, Fabre M, Vilaro S. 2006. The transcription factors Slug and Snail act as repressors of Claudin-1 expression in epithelial cells. Biochem J 394(Pt 2):449-457.
29. Menendez JA, Vellon L, Colomer R, Lupu R. 2005. Effect of gamma-linolenic acid on the transcriptional activity of the Her-2/neu (erbB-2) oncogene. J Natl Cancer Inst 97(21):1611-1615.
30. Morin PJ. 2005. Claudin proteins in human cancer: Promising new targets for diagnosis and therapy. Cancer Res 65(21):9603-9606.
31. Nguyen DA, Parlow AF, Neville MC. 2001. Hormonal regulation of tight junction closure in the mouse mammary epithelium during the transition from pregnancy to lactation. J Endocrinol 170(2):347-356.
32. Sawada N, Murata M, Kikuchi K, Osanai M, Tobioka H, Kojima T, Chiba H. 2003. Tight junctions and human diseases. Med Electron Microsc 36(3):147-156.
33. Shah YM, Kaul A, Dong Y, Ip C, Rowan BG. 2005. Attenuation of estrogen receptor alpha (ERalpha) signaling by selenium in breast cancer cells via downregulation of ERalpha gene expression. Breast Cancer Res Treat 92(3):239-250.
34. Shilo S, Aronis A, Komarnitsky R, Tirosh O. 2003. Selenite sensitizes mitochondrial permeability transition pore opening in vitro and in vivo: A possible mechanism for chemo-protection. Biochem J 370(Pt 1):283-290.
35. Shrivastava A, Tiwari M, Sinha RA, Kumar A, Balapure AK, Bajpai VK, Sharma R, Mitra K, Tandon A, Godbole MM. 2006. Molecular iodine induces caspase-independent apoptosis in human breast carcinoma cells involving the mitochondria-mediated pathway. J Biol Chem 281(28):19762-19771.
36. Singh P, Kapil U, Shukla NK, Deo S, Dwivedi SN. 2005. Association between breast cancer and vitamin C, vitamin E and selenium levels: Results of a case-control study in India. Asian Pac J Cancer Prev 6(2):177-180.
37. Soini Y. 2005. Expression of claudins 1, 2, 3, 4, 5 and 7 in various types of tumours. Histopathology 46(5):551-560.
38. Streicher KL, Sylte MJ, Johnson SE, Sordillo LM. 2004. Thioredoxin reductase regulates angiogenesis by increasing endothelial cell-derived vascular endothelial growth factor. Nutr Cancer 50(2):221-231.
39. Tsukita S, Furuse M. 1999. Occludin and claudins in tight-junction strands: Leading or supporting players? Trends Cell Biol 9(7):268-273.
40. Vishniakova W, Murav'eva NI. 1966. On the treatment of dyshormonal hyperplasia of mammary glands. Vestn Akad Med Nauk SSSR 21(9):19-22.
41. Wong V. 1997. Phosphorylation of occludin correlates with occludin localization and function at the tight junction. Am J Physiol 273(6 Pt 1):C1859-C1867.
42. Wong V, Gumbiner BM. 1997. A synthetic peptide corresponding to the extracellular domain of occludin perturbs the tight junction permeability barrier. J Cell Biol 136(2):399-409.
43. Yamagata K, Tagami M, Takenaga F, Yamori Y, Nara Y, Itoh S. 2003. Polyunsaturated fatty acids induce tight junctions to form in brain capillary endothelial cells. Neuroscience 116(3):649-656.
44. Ye L, Martin TA, Parr C, Harrison GM, Mansel RE, Jiang WG. 2003. Biphasic effects of 17-beta-estradiol on expression of occludin and transendothelial resistance and paracellular permeability in human vascular endothelial cells. J Cell Physiol 196(2):362-369.